OncoQR ML OG

CONSULTING / FUNDING (a Capricorn Consilium Project)

Wanted: Biotech advisor with contacts to potential strategic partners and venture capital firms for funding of further company and product development.

The Client

OncoQR ML OG is a biotech start-up company founded in September 2013 in Vienna, Austria, which develops novel therapeutic vaccines to cure cancer. OncoQR’s vaccines are directed against important tumours like pancreatic, breast or lung cancer and can be regarded as a more potent alternative to monoclonal antibodies.

www.oncoqr.com

The Assignment

With private capital as well as public pre-seed and seed money, OncoQR was able to demonstrate preclinical proof-of-concept in a relevant animal model. Further funding was required either from venture capital (VC) firms or via strategic partners.

The Solution

Capricorn Consilium compiled a list of potential strategic partners in the field of oncology as well as selected vaccine players with a link to oncology and a list of venture capital companies investing in early-stage biotech companies. Each firm was contacted several times, telephone conferences and business meetings have been organised. Negotiations with the short-listed candidates are still ongoing.